170 related articles for article (PubMed ID: 4900342)
1. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
Burke G; Silverstein GE
JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342
[No Abstract] [Full Text] [Related]
2. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
3. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
Adlkofer F; Schleusener H; Uher L; Ananos A
Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
[No Abstract] [Full Text] [Related]
4. [Hypothyroidism following treatment of hyperthyroidism with radioactive iodine (I 131 )].
Gasiorowski W; Rusiecka-Wojciechowska E; Jeske E
Minerva Med; 1973 Feb; 64(9):425-8. PubMed ID: 4121076
[No Abstract] [Full Text] [Related]
5. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
6. Low-dose sodium iodide I 131 therapy in Graves disease.
Rapoport B; Caplan R; DeGroot LJ
JAMA; 1973 Jun; 224(12):1610-3. PubMed ID: 4122436
[No Abstract] [Full Text] [Related]
7. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
8. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
9. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
10. Graves' disease in the male. A review of 241 cases treated with an individually calculated dose of sodium iodide I 131.
Blahd WH; Hays MT
Arch Intern Med; 1972 Jan; 129(1):33-40. PubMed ID: 5066656
[No Abstract] [Full Text] [Related]
11. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
12. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
13. Comparison of high and low dosage levels of 131-I in the treatment of thyrotoxicosis.
Hagen GA; Ouellette RP; Chapman EM
N Engl J Med; 1967 Sep; 277(11):559-62. PubMed ID: 4166909
[No Abstract] [Full Text] [Related]
14. [Late side effects of radioactive iodine therapy in hyperthyroidism].
Hara M; Kitabatake T
Rinsho Hoshasen; 1973 Aug; 48(8):527-41. PubMed ID: 4581355
[No Abstract] [Full Text] [Related]
15. [Graves-Basedow type ophthalmopathy and primary hypothyroidism].
Cathelineau G; Fribourg-Desi M
Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586
[No Abstract] [Full Text] [Related]
16. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
[No Abstract] [Full Text] [Related]
17. Ophthalmic Graves' disease. Diagnosis and pathogenesis.
Hall R; Kirkham K; Doniach D; el-Kabir D
Lancet; 1970 Feb; 1(7643):375-8. PubMed ID: 4189686
[No Abstract] [Full Text] [Related]
18. Long-acting thyroid stimulator in Graves' disease.
Sellers EA; Awad AG; Schönbaum E
Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
[No Abstract] [Full Text] [Related]
19. Studies on the pathogenesis of the ophthalmopathy of Graves' disease.
Kriss JP; Pleshakov V; Rosenblum AL; Holderness M; Sharp G; Utiger R
J Clin Endocrinol Metab; 1967 Apr; 27(4):582-93. PubMed ID: 6071430
[No Abstract] [Full Text] [Related]
20. Etiology and treatment of hyperthyroidism in the adult.
J Clin Endocrinol Metab; 1967 Dec; 27(12):1763-77. PubMed ID: 4168656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
